{"result": "(\"entity\"<|>TUMORES HIPOFISARIOS<|>EVENT<|>Los tumores hipofisarios son neoplasias que se desarrollan en la glándula pituitaria y pueden secretar hormonas como TSH, GH, entre otras, afectando diversas funciones corporales.)\n##\n(\"entity\"<|>SOMATOSTATINA<|>ORGANIZATION<|>La somatostatina es una hormona que inhibe la secreción de otras hormonas y se utiliza en el tratamiento de tumores hipofisarios.)\n##\n(\"entity\"<|>RECEPTORES DE SOMATOSTATINA<|>ORGANIZATION<|>Los receptores de somatostatina son proteínas que se encuentran en la superficie de las células y que permiten la acción de la somatostatina en el cuerpo.)\n##\n(\"entity\"<|>ADENOMAS HIPOFISARIOS<|>EVENT<|>Los adenomas hipofisarios son tumores benignos que se originan en la glándula pituitaria y pueden causar hipersecreción hormonal.)\n##\n(\"entity\"<|>GRADO 2<|>EVENT<|>El grado 2 en la clasificación de Knosp se refiere a la invasión de los tumores hipofisarios en el seno cavernoso, donde el tumor empuja la pared medial pero no sobrepasa la línea tangencial lateral.)\n##\n(\"entity\"<|>MUTACIONES DE LA PROTEÍNA GS<|>EVENT<|>Las mutaciones de la proteína GS están asociadas con un porcentaje significativo de tumores hipofisarios que secretan GH.)\n##\n(\"entity\"<|>GENES AIP Y PRKAR1A<|>ORGANIZATION<|>Los genes AIP y PRKAR1A están implicados en la patogénesis de los adenomas hipofisarios, afectando su desarrollo y características.)\n##\n(\"relationship\"<|>TUMORES HIPOFISARIOS<|>SOMATOSTATINA<|>Los tumores hipofisarios productores de TSH utilizan análogos de somatostatina como parte de su tratamiento<|>7)\n##\n(\"relationship\"<|>TUMORES HIPOFISARIOS<|>RECEPTORES DE SOMATOSTATINA<|>Los tumores hipofisarios expresan receptores de somatostatina, lo que influye en su respuesta a los tratamientos<|>8)\n##\n(\"relationship\"<|>ADENOMAS HIPOFISARIOS<|>MUTACIONES DE LA PROTEÍNA GS<|>Las mutaciones de la proteína GS están presentes en adenomas hipofisarios, afectando su comportamiento<|>6)\n##\n(\"relationship\"<|>ADENOMAS HIPOFISARIOS<|>GENES AIP Y PRKAR1A<|>Los genes AIP y PRKAR1A están implicados en la patogénesis de los adenomas hipofisarios<|>5)\n##\n(\"relationship\"<|>GRADO 2<|>ADENOMAS HIPOFISARIOS<|>El grado 2 en la clasificación de Knosp se refiere a la invasión de adenomas hipofisarios en el seno cavernoso<|>4)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: (respuesta B).\n\nLos tumores hipofisarios productores de TSH expresan receptores de somatostatina, y por eso los análogos de somatostatina se utilizan como parte del tratamiento (para conseguir el eutiroidismo precirugía o incluso como tratamiento primario). La mayoría suelen expresar el subtipo 2, pero también expresan otros, y precisamente el patrón de expresión de receptores de somatostatina parece influir en la respuesta tumoral a los análogos. Se cree que aquellos que expresan los subtipos 2 y 5 de los receptores de somatostatina tienen mejor respuesta tumoral a los análogos de somatostatina.\n\n## Señale la afirmación falsa:\n\nA. Según la clasificación de Knosp de los tumores hipofisarios, el grado 2 se considera cuando el tumor se extiende lateralmente a la línea tangencial lateral que une ambas carótidas.\nB. Las mutaciones de la proteína GS están presentes en hasta el 40% de los tumores secretores de GH.\nC. Las mutaciones en los genes AIP y PRKAR1A pueden estar implicadas en la patogénesis de los adenomas hipofisarios.\nD. Los tumores hipofisarios productores de TSH suelen expresar receptores para la somatostatina (SSTR2).\n\n### COMENTARIO\n\nLa clasificación de Knosp (fig. 1) valora la invasión del seno cavernoso por parte de los tumores hipofisarios y se basa en cortes coronales de la RMN. Se gradúa de 0 a 4, y los grados 3-4 son los que definen la verdadera invasión del seno cavernoso:\n\n- Grado 0: sin afectación del seno cavernoso.\n- Grado 1: el tumor empuja la pared medial del seno cavernoso, pero no sobrepasa la hipotética línea que une de centro a centro las dos porciones de la carótida interna.\n- Grado 2: el tumor empuja la pared medial del seno cavernoso y sobrepasa la línea intercarotídea central, pero no la tangente lateral externa intercarotídea (opción A falsa).\n- Grado 3: el tumor supera esa tangente lateral externa intercarotídea y se mete en el seno cavernoso.\n- Grado 4: el tumor rodea completamente la arteria carotídea intracavernosa.\n\n| GRADO 0 | GRADO 1 | GRADO 2 |\n|---------|---------|---------|\n| [Imagen del grado 0] | [Imagen del grado 1] | [Imagen del grado 2] |\n\n| GRADO 3 | GRADO 4 |\n|---------|---------|\n| [Imagen del grado 3] | [Imagen del grado 4] |\n\nFigura 1. Clasificación de Knosp.\n\nReferencias:\n- Castaño I, Martínez de la Piscina I, Portillo N, Rica I. Adenomas hipofisarios: Impacto clínico de los hallazgos moleculares. Rev Esp Endocrinol Pediatr. 2017;8(Suppl):35-45.\n- Clemente Gallego D, Ramírez de Molina V, Lucas Morante T. Manual de Endocrinología y Nutrición [Internet]. Madrid: Sociedad Española de Endocrinología y Nutrición; 2015. Capítulo 13. Hipersecreción de hormona del crecimiento: Acromegalia y gigantismo; [citado 29 de abril de 2019]. Disponible en: https://manual.seen.es/article?id=55114b66-489c-4c70-8a67-2bcdac18103c\n- Edal AL, Skjödt K, Nepper-Rasmussen HJ. SIPAP: A new MR classification for pituitary adenomas. Acta Radiologica. 1997;38(1):30-6.\n- Knosp E, Steiner E, Kitz K, Matula C. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery. 1993;33(4):610-7.\n- Weiss RE, Refetoff S. TSH-secreting pituitary adenomas. En: Ross DS, Mulder JE, eds. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com (acceso el 29 de abril de 2019).\n---\n# HIPÓFISIS 1\n\n## 19. Se consideran tumores hipofisarios agresivos todos excepto:\n\nA. Adenoma somatotropo densamente granulado.\nB. Adenoma de células de Crooke.\nC. Adenoma plurihormonal.\nD. Corticotropinoma silente.\n\n### COMENTARIO\n\nEn 2017 se publicó una actualización en la clasificación de la OMS de los tumores hipofisarios, que ha supuesto algunos cambios respecto a las previas.\n\nUno de los fundamentales es que se abandona el concepto de \"adenoma hipofisario productor de una hormona\". En cambio, los adenomas se designan en\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}